AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2025
Jun 12, 2025
31542_dirs_2025-06-12_64051016-055d-46a9-a57a-9f422ba36782.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-06-10
Reporting Person: Sundaram Preethi (Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-10 | Common Stock, par value $0.001 per share | S | 2324 | $26.41 | Disposed | 42681 | Direct |
| 2025-06-11 | Common Stock, par value $0.001 per share | S | 1600 | $26.42 | Disposed | 41081 | Direct |
Footnotes
F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2: Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.49 per share.
F3: Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.48 per share.
More from CATALYST PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2025
Dec 30